Abbio Therapeutics is a dynamic and growing pharmaceutical company headquartered in Greece, with a strong international outlook and a focus on the development, licensing, and commercialization of high-value pharmaceutical products.

Founded by experienced pharmaceutical executives with strong scientific expertise and in-depth knowledge of the regulatory and commercial landscape, Abbio Therapeutics combines scientific excellence with market insight and operational agility.

Our portfolio comprises products originating from both our in-house Research & Development (R&D) program and strategic partnerships with international pharmaceutical companies, developers, and specialized manufacturers.